Wiciński, M.; Socha, M.; Malinowski, B.; Wódkiewicz, E.; Walczak, M.; Górski, K.; Słupski, M.; Pawlak-Osińska, K.
Liraglutide and its Neuroprotective Properties—Focus on Possible Biochemical Mechanisms in Alzheimer’s Disease and Cerebral Ischemic Events. Int. J. Mol. Sci. 2019, 20, 1050.
https://doi.org/10.3390/ijms20051050
AMA Style
Wiciński M, Socha M, Malinowski B, Wódkiewicz E, Walczak M, Górski K, Słupski M, Pawlak-Osińska K.
Liraglutide and its Neuroprotective Properties—Focus on Possible Biochemical Mechanisms in Alzheimer’s Disease and Cerebral Ischemic Events. International Journal of Molecular Sciences. 2019; 20(5):1050.
https://doi.org/10.3390/ijms20051050
Chicago/Turabian Style
Wiciński, Michał, Maciej Socha, Bartosz Malinowski, Eryk Wódkiewicz, Maciej Walczak, Karol Górski, Maciej Słupski, and Katarzyna Pawlak-Osińska.
2019. "Liraglutide and its Neuroprotective Properties—Focus on Possible Biochemical Mechanisms in Alzheimer’s Disease and Cerebral Ischemic Events" International Journal of Molecular Sciences 20, no. 5: 1050.
https://doi.org/10.3390/ijms20051050
APA Style
Wiciński, M., Socha, M., Malinowski, B., Wódkiewicz, E., Walczak, M., Górski, K., Słupski, M., & Pawlak-Osińska, K.
(2019). Liraglutide and its Neuroprotective Properties—Focus on Possible Biochemical Mechanisms in Alzheimer’s Disease and Cerebral Ischemic Events. International Journal of Molecular Sciences, 20(5), 1050.
https://doi.org/10.3390/ijms20051050